Rapiscan
regadenoson
Myocardial Perfusion Imaging
Date of authorisation:
Revision: 15
Last updated:
MedicineHumanAuthorised
Thymanax
Agomelatine
Depressive Disorder, Major
Date of authorisation:
Date of refusal:
Revision: 24
Last updated:
MedicineHumanWithdrawn
EMEA-000410-PIP01-08-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Cardiovascular diseases
PIP number: P/0030/2019
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Thymanax
Agomelatine
Depressive Disorder, Major
Date of refusal:
Last updated:
MedicineHumanRefused